SynergyMed
Medical Devices for Human and Veterinary Cancer Treatment
Company Overview
Snapshot
Founded in January 2018 by Anan Copty, SynergyMed operates with 11–50 employees. The company is currently in the Pre-Funding stage, focusing on the development of medical devices for cancer treatment.
Business overview
SynergyMed is an early-stage startup developing non-invasive medical devices for cancer treatment, applicable in both human and veterinary medicine. The company's core technology aims to replace surgical tumor resection with a system designed for rapid and effective ablation and destruction of tumors, while preserving healthy surrounding tissue. SynergyMed operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics, serving healthcare providers and pet owners across Europe, Asia, and North America.
Log in to access full profile ›Company Intelligence Q&A
- What is SynergyMed's primary focus?
- SynergyMed develops medical devices for cancer treatment, applicable in both human and veterinary medicine.
- When was SynergyMed founded?
- SynergyMed was founded in January 2018.
- Who founded SynergyMed?
- SynergyMed was founded by Anan Copty.
- What is SynergyMed's primary technology?
- SynergyMed's primary technology is a noninvasive system designed to ablate and destroy cancerous tumors without surgical resection or damage to healthy tissue.
- In which markets does SynergyMed operate?
- SynergyMed targets markets in Europe, Asia, and North America.